Marked alteration of glycemic profile surrounding lanreotide administration in acromegaly: A case report

Whether somatostatin analogs for acromegaly improve or worsen a patient's glycemic profile is controversial. A risk of hypoglycemia should be presumed, especially when patients receive insulin therapy, as the package inserts caution. However, a detailed clinical course of such a case has never...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Sho, Haketa, Akira, Yamamuro, Shun, Suzuki, Toshiko, Kobayashi, Hiroki, Hatanaka, Yoshinari, Ueno, Takahiro, Fukuda, Noboru, Abe, Masanori, Yoshino, Atsuo, Soma, Masayoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754526/
https://www.ncbi.nlm.nih.gov/pubmed/28390105
http://dx.doi.org/10.1111/jdi.12675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754526/
https://www.ncbi.nlm.nih.gov/pubmed/28390105
http://dx.doi.org/10.1111/jdi.12675

Ejemplares similares